HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson's disease.

Abstract
The prominent protective effects in diverse neuron injury paradigms exerted by cannabinoids and in particular their endogenously produced species render the endocannabinoid system a promising molecular target in the treatment of neurodegenerative diseases. However, the effects of individual endocannabinoids in human cells remain poorly investigated. Neural derivatives of human induced pluripotent stem cells (iPSC) offer unique opportunities for studying the neuroprotective compounds and development of patient-specific treatment. For the first time the cytotoxic and neuroprotective effects endocannabinoids N-arachidonoyl dopamine (N-ADA) and N-docosahexaenoyl dopamine (N-DDA) were assessed in human neural progenitors and dopamine neurons derived from iPSCs of healthy donors and patients with Parkinson's disease. While the short-term treatment with the investigated compounds in 0.1-10 μM concentration range exerted no toxicity in these cell types, the long-term exposure to 0.1-5 μM N-ADA or N-DDA reduced the survival of human neural progenitors. At the same time, both N-ADA and N-DDA protected neural progenitors and terminally differentiated neurons both from healthy donors and patients with Parkinson's disease against oxidative stress induced by hydrogen peroxide. The observed dramatic difference in the mode of action of N-acyl dopamines points on the possible existence of novel pathogenic mechanism of neurodegeneration induced by prolonged uncompensated production of these substances within neuronal tissue and should also be considered as a precaution in the future development of N-acyl dopamine-based therapeutic drugs.
AuthorsEkaterina Novosadova, Stanislav Antonov, Elena Arsenyeva, Andrey Kobylanskiy, Yulia Vanyushina, Tatyana Malova, Leonid Khaspekov, Mikhail Bobrov, Vladimir Bezuglov, Vyacheslav Tarantul, Sergey Illarioshkin, Igor Grivennikov
JournalNeurotoxicology (Neurotoxicology) Vol. 82 Pg. 108-118 (01 2021) ISSN: 1872-9711 [Electronic] Netherlands
PMID33248189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Arachidonic Acids
  • Endocannabinoids
  • N-docosahexaenoyl dopamine
  • Neuroprotective Agents
  • arachidonyl dopamine
  • Dopamine
Topics
  • Arachidonic Acids (pharmacology, toxicity)
  • Cell Death (drug effects)
  • Cell Line
  • Dopamine (analogs & derivatives, pharmacology, toxicity)
  • Endocannabinoids (pharmacology, toxicity)
  • Fluorescent Antibody Technique
  • Humans
  • Induced Pluripotent Stem Cells (drug effects)
  • Neurons (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Stress (drug effects)
  • Parkinson Disease (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: